Antiplatelet Drug

DRUG11 trials

Sponsors

Inoue Hiroyasu, Beijing Jishuitan Hospital, Biosensors Europe SA, National Hospital Organization Osaka National Hospital, National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Conditions

Acute Coronary SyndromeAneurysmal Subarachnoid HemorrhageAntiphospholipid SyndromeAntiplatelet DrugsAtherothrombosisAtrial FibrillationCardiac ArrestCardiovascular Diseases

Phase 4

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

TerminatedNCT03062319

National Hospital Organization Osaka National HospitalAtherothrombosis, Atrial Fibrillation, Ischemic Stroke

Start: 2017-04-06End: 2023-07-18Updated: 2024-12-27

Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

Active, not recruitingNCT05122780

Fondazione Policlinico Universitario Agostino Gemelli IRCCSMyocardial Infarction With Non-Obstructive Coronary Arteries

Start: 2021-07-01End: 2025-07-31Updated: 2024-07-26

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

RecruitingNCT05995600

Seoul National University HospitalAntiphospholipid Syndrome, Cardiovascular Diseases, Cerebrovascular Disease +3

Start: 2024-02-20End: 2029-03-31Target: 200Updated: 2024-10-16

Unknown Phase

Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis

CompletedNCT02800174

Beijing Jishuitan HospitalCarotid Artery Stenosis

Start: 2006-06-30End: 2008-06-30Updated: 2016-06-15

LEADERS FREE II: BioFreedom™ Pivotal Study

Active, not recruitingNCT02843633

Biosensors Europe SAAcute Coronary Syndrome, High Bleeding Risk

Start: 2017-02-14End: 2021-03-31Updated: 2021-02-03

REGistry of Long-term AnTithrombotic TherApy-1

RecruitingNCT04347200

National Medical Research Center for Cardiology, Ministry of Health of Russian FederationCoronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Peripheral Artery Disease

Start: 2015-01-15End: 2026-01-31Target: 2000Updated: 2025-03-18

Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage

Nanjing Medical UniversityAneurysmal Subarachnoid Hemorrhage

Start: 2019-11-01End: 2021-12-31Target: 200Updated: 2020-09-14

Type 2 Diabetes With Antiplatelet Drugs

CompletedNCT05053828

Tabula Rasa HealthCareAntiplatelet Drugs, Heart Failure, Myocardial Infarction +1

Start: 2021-09-20End: 2023-01-30Updated: 2023-01-31

Active, not recruitingJPRN-jRCT1041220038

Inoue HiroyasuIschemic stroke Branch atheromatous disease

Start: 2022-09-14Target: 50Updated: 2025-07-18

Carotid Web and Stroke Registry.

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauCarotid Web, Stroke

Start: 2022-07-15End: 2025-07-15Target: 100Updated: 2022-08-01

Monitoring Antiplatelet Drugs in Cardiac Arrest Patients

University of Milano BicoccaCardiac Arrest, Extracorporeal Membrane Oxygenation, Myocardial Infarction +1

Start: 2022-10-01End: 2024-10-30Target: 60Updated: 2023-02-15

Related Papers

Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.

2025-12-012 citations

Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial.

2025-11-25

Efficacy and safety of various regimens of multiagent antithrombotic therapy in patients with multifocal atherosclerosis (data from real-world practice)

CARDIOVASCULAR THERAPY AND PREVENTION2025-08-17

Optimal antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis: study protocol for a randomized controlled trial

Frontiers in Neurology2024-10-231 citations

Clinical outcomes with thin versus thick strut polymer-free biolimus-coated stents at 3 years

Open Heart2024-06-011 citations

Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials

Circulation Cardiovascular Interventions2024-04-0116 citations

Sensitivity to clopidogrel and outcomes of long-term dual antiplatelet therapy in patients with multifocal atherosclerosis

Aterotromboz = Atherothrombosis2024-01-161 citations

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

Terapevticheskii arkhiv2023-11-032 citations

Factors determining the prognosis after elective myocardial revascularization in patients with coronary artery disease with multifocal atherosclerosis

CARDIOVASCULAR THERAPY AND PREVENTION2023-09-06

Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial

EuroIntervention2022-12-0141 citations

Oral Presentation No. 03 Growth differentiation factor-15 and bleeding complication risk in patients with coronary artery disease, receiving combined antithrombotic therapy

Cardiovascular Research2022-10-01

Oral Presentation No. 41 High plasma von Willebrand factor concentration is associated with the development of bleeding complications in patients with polyvascular disease receiving multicomponent antithrombotic therapy

Cardiovascular Research2022-10-01

Relationship between the D-dimer and von Willebrand factor levels and the development of gastrointestinal bleeding in patients with stable coronary artery disease: data from the registry of long-term antithrombotic therapy REGATTA-1

CARDIOVASCULAR THERAPY AND PREVENTION2021-11-284 citations

High plasma D-dimer and von Willebrand factor levels are associated with risk of upper gastrointestinal bleeding in patients with chronic coronary syndromes receiving long-term antiplatelet therapy

European Heart Journal2021-10-01

Risk factors and outcomes of gastrointestinal bleeding in patients with stable coronary artery disease: data from the observational registry of long-term antithrombotic therapy REGATTA-1

Russian Journal of Cardiology2021-07-169 citations

Peripheral atherosclerosis and abdominal aortic aneurysm as a new risk factors of upper gastrointestinal bleeding in patients with stable CAD receiving long-term antithrombotic therapy

European Journal of Preventive Cardiology2021-05-011 citations

Performance of PRECISE-DAPT Score for predicting upper gastrointestinal bleedings in patients with stable coronary artery disease on long-term antithrombotic therapy

European Journal of Preventive Cardiology2021-05-01

Upper gastrointestinal bleeding in patients with stable coronary artery disease (registry of antithrombotic therapy “REGATТA” results)

Terapevticheskii arkhiv2020-10-1410 citations

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy

JAMA Cardiology2020-05-2033 citations

Use of the Smart nitinol stent system for the treatment of severe atherosclerotic carotid stenosis: study protocol for a retrospective, non-randomized, long-term parallel controlled trial

Clinical and Translational Degenerative Diseases2016-01-01